227 related articles for article (PubMed ID: 3420871)
21. [Treatment of ischemic brain lesions].
Eichhorn O
Med Welt; 1969 Oct; 42():2314-8. PubMed ID: 4982284
[No Abstract] [Full Text] [Related]
22. [Treatment of circulatory encephalopathy with Cavinton].
Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
[No Abstract] [Full Text] [Related]
23. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
Tamaki N; Kusunoki T; Matsumoto S
Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
[No Abstract] [Full Text] [Related]
24. [Vincamine in cerebral arteriosclerosis: therapeutic effects evaluated clinically and by retinal fluoro-angiography].
Ardito R
Clin Ter; 1979 Mar; 88(5):461-12. PubMed ID: 466968
[No Abstract] [Full Text] [Related]
25. [Effect of antianginal agents on the cerebral circulatory indices in cerebral arteriosclerosis].
Eninia GI; Smeltere ES; Godlevska MA; Logina IP
Klin Med (Mosk); 1985 Sep; 63(9):45-8. PubMed ID: 4068626
[No Abstract] [Full Text] [Related]
26. [Prospects of using cavinton for treating Ménière's disease].
Nikolaev MP; Konstantinova ZD; Mertsalova ON; Sheremet AS
Vestn Otorinolaringol; 1980; (3):18-22. PubMed ID: 7385520
[No Abstract] [Full Text] [Related]
27. [A comparative evaluation of the effect of vasodilator drugs on the cerebral vessels of patients with cerebral atherosclerosis (rheoencephalographic studies)].
Eninie GI; Smeltere ES
Klin Med (Mosk); 1972 Sep; 50(9):39-44. PubMed ID: 4652968
[No Abstract] [Full Text] [Related]
28. [10-year experience with using Cavinton in cerebrovascular disorders].
Burtsev EM; Savkov VS; Shprakh VV; Burtsev ME
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):56-60. PubMed ID: 1319651
[TBL] [Abstract][Full Text] [Related]
29. The cerebral hemodynamic effect of Vincamine.
Depresseux JC
Acta Neurol Scand Suppl; 1977; 64():408-9. PubMed ID: 268852
[No Abstract] [Full Text] [Related]
30. [Effect of kavinton on systemic and regional hemodynamics in waking and anesthetized rats].
Ivashev MN; Martynova ER; Medvedev OS
Farmakol Toksikol; 1989; 52(1):26-9. PubMed ID: 2707414
[TBL] [Abstract][Full Text] [Related]
31. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
Man'kovskiĭ NB; Mints AIa; Karaban' IN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
[TBL] [Abstract][Full Text] [Related]
32. [Clinical tests, in psychiatry, of a modifier of cerebral circulation: 1035 M.D].
Porot M; Couadau A; Petit G; Lajoinie J
Ann Med Psychol (Paris); 1968 Mar; 1(3):442-7. PubMed ID: 5670017
[No Abstract] [Full Text] [Related]
33. Principles of pharmacologic correction of neurologic disorders in initial atherosclerotic encephalopathy.
Man'kovsky NB; Minz AY
Gerontology; 1988; 34(1-2):75-81. PubMed ID: 3384341
[TBL] [Abstract][Full Text] [Related]
34. Radiocirculographic study of the effect of ethyl apovincaminate on the cerebral circulation.
Fényes S; Földes J
Arzneimittelforschung; 1976; 26(10a):1963-4. PubMed ID: 798589
[TBL] [Abstract][Full Text] [Related]
35. [Regional cerebral blood flow and its regulation in the initial stage of cerebral arteriosclerosis].
Man'kovskiĭ NB; Mints AIa; Lizogub VG; Kim B
Klin Med (Mosk); 1979 Sep; 57(9):35-9. PubMed ID: 40063
[No Abstract] [Full Text] [Related]
36. [Treatment of patients with initial manifestations of cerebral circulation insufficiency in vasomotor dystonias].
Kanareĭkin KF; Manvelov LS
Klin Med (Mosk); 1992; 70(5-6):56-60. PubMed ID: 1434406
[No Abstract] [Full Text] [Related]
37. Cerebral regulation-cerebral regulators.
Braun P
Ther Hung; 1980; 28(3):98-104. PubMed ID: 7221974
[No Abstract] [Full Text] [Related]
38. [Effect of sulfocamphocaine on the systemic and cerebral hemodynamics of patients with chronic cerebral circulatory failure].
Ishchenko MM; Shkrobot SI
Vrach Delo; 1984 Jul; (7):68-70. PubMed ID: 6475025
[No Abstract] [Full Text] [Related]
39. [The safe use of cavinton forte in discirculatory encephalopathy].
Protasov KV; Dzizinskiĭ AA; Shprakh VV; Sinkevich DA; Kuklin SG; Filatova LN
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):55-7. PubMed ID: 16548377
[No Abstract] [Full Text] [Related]
40. Ethyl apovincaminate therapy in neurovascular diseases.
Szobor A; Klein M
Arzneimittelforschung; 1976; 26(10a):1984-9. PubMed ID: 1037230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
